# Fimepinostat in Treating Brain Tumors in Children and Young Adults

> **NCT03893487** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Sabine Mueller, MD, PhD** · enrollment: 30 (actual)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma
- Recurrent Anaplastic Astrocytoma
- Recurrent Glioblastoma
- Recurrent Malignant Glioma
- Recurrent Medulloblastoma

## Interventions

- **DRUG:** Fimepinostat
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT03893487
- **Lead sponsor:** Sabine Mueller, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-08-07
- **Primary completion:** 2022-10-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03893487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03893487, "Fimepinostat in Treating Brain Tumors in Children and Young Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03893487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*